Picture of Malin logo

MLC Malin News Story

0.000.00%
ie flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

REG - Malin Corp PLC - Leadership Update

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230705:nRSE9792Ea&default-theme=true

RNS Number : 9792E  Malin Corporation PLC  05 July 2023

Malin Corporation plc

 

Leadership Update

 

Dublin-Ireland, 5 July 2023: Malin Corporation plc. (Euronext Growth
Dublin:MLC) ("Malin", the "Company"), today announces that following Malin's
significant capital realisations and shareholder returns over the past four
years, its Chief Executive Officer ("CEO"), Darragh Lyons, will leave the
Company before the end of 2023. Fiona Dunlevy will assume the role of
Executive Director from 2 October 2023 and join Malin's board of directors.
Malin's Chairman, Liam Daniel, will also undertake additional responsibilities
as an Executive Chairman from 2 October 2023.  The leadership of the Company
will transition from Mr Lyons to Ms Dunlevy and Mr Daniel over the following
period and they will continue the work to maximise shareholder returns by
protecting and enhancing the value of Malin's remaining positions in its
investee companies. Mr Lyons will step down as member of the board on his
departure as CEO. The leadership changes are consistent with the continuous
aim of operating within a lean and efficient infrastructure that is aligned
with the breadth of the underlying assets.

 

Commenting on the leadership changes, Mr Daniel stated, "Darragh has
successfully led the Malin business since 2019 and during this time, Malin has
made considerable progress in executing on its business strategy and returning
capital to shareholders. We thank Darragh for his work and significant
contributions to Malin over the years and wish him well in the future. The
board of directors is delighted that Fiona Dunlevy, who has been with Malin in
various leadership roles since 2015 and most recently served as Company
Secretary, has agreed to work with me in leading the business going forward.
Darragh will work closely with Fiona and me over the coming months to ensure
that there is a comprehensive transition of leadership responsibilities."

 

Ms. Dunlevy added, "I am delighted to take up the role of Executive Director
in Malin and to work alongside Liam to continue the work to maximise
shareholder returns. Having worked closely with Darragh in managing our assets
for several years, I believe that there is significant additional value
creation potential in our remaining assets which can support additional
returns of capital to our shareholders."

 

ENDS
 

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative
life sciences companies. Its purpose is to create shareholder value through
the application of long-term capital and operational and strategic expertise
to a diverse range of global healthcare businesses. Malin has a focus on
innovative businesses underpinned by exceptional science and works with its
investee companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and domiciled in
Ireland and listed on the Euronext Growth Dublin. For more information
visit www.malinplc.com (http://www.malinplc.com/)

For further information please contact:

Malin

Andrea Stafford, Head of Finance

Tel: +353 (0)1 901 5700

investorrelations@malinplc.com (mailto:investorrelations@malinplc.com)

 

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

 

Liberum (Joint Broker)

Phil Walker / Ben Cryer

Tel: +44 (0) 20 3100 2000

 

Powerscourt (Media enquiries)

Eavan Gannon

Tel: +353 87 236 5973

malin@powerscourt-group.com (mailto:malin@powerscourt-group.com)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDUSOKROOUBRAR

Recent news on Malin

See all news